A clinical trial of NVG-291 peptide drug demonstrates promising results for spinal cord injury patients, with participant ...

EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6. The expansion cohort for pancreatic ductal ...

Investors in the biotechnology space have been treated to a couple of big fireworks displays recently. During the month ...

CureVac's experimental COVID-19 vaccine triggered an immune response in humans, the German biotech firm said on Monday, putting it on track to start mass testing this year as the race to end the ...

Montana just passed a new bill backed by longevity enthusiasts that will enable access to drugs and therapies that are not approved by the FDA. A bill that allows medical clinics to sell unproven ...

Turkey began final Phase III trials of an experimental Chinese coronavirus vaccine on Wednesday, the health minister said.